11-6616033-G-C

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_000391.4(TPP1):​c.1117C>G​(p.Gln373Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00147 in 1,614,168 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0075 ( 14 hom., cov: 32)
Exomes 𝑓: 0.00085 ( 6 hom. )

Consequence

TPP1
NM_000391.4 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.26

Publications

5 publications found
Variant links:
Genes affected
TPP1 (HGNC:2073): (tripeptidyl peptidase 1) This gene encodes a member of the sedolisin family of serine proteases. The protease functions in the lysosome to cleave N-terminal tripeptides from substrates, and has weaker endopeptidase activity. It is synthesized as a catalytically-inactive enzyme which is activated and auto-proteolyzed upon acidification. Mutations in this gene result in late-infantile neuronal ceroid lipofuscinosis, which is associated with the failure to degrade specific neuropeptides and a subunit of ATP synthase in the lysosome. [provided by RefSeq, Jul 2008]
TPP1 Gene-Disease associations (from GenCC):
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Myriad Women’s Health, Genomics England PanelApp, PanelApp Australia
  • autosomal recessive spinocerebellar ataxia 7
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 11 uncertain in NM_000391.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0070130825).
BP6
Variant 11-6616033-G-C is Benign according to our data. Variant chr11-6616033-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 137701.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00745 (1135/152294) while in subpopulation AFR AF = 0.0258 (1071/41548). AF 95% confidence interval is 0.0245. There are 14 homozygotes in GnomAd4. There are 535 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000391.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TPP1
NM_000391.4
MANE Select
c.1117C>Gp.Gln373Glu
missense
Exon 9 of 13NP_000382.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TPP1
ENST00000299427.12
TSL:1 MANE Select
c.1117C>Gp.Gln373Glu
missense
Exon 9 of 13ENSP00000299427.6O14773-1
TPP1
ENST00000533371.6
TSL:1
c.388C>Gp.Gln130Glu
missense
Exon 8 of 12ENSP00000437066.1O14773-2
TPP1
ENST00000895469.1
c.1117C>Gp.Gln373Glu
missense
Exon 9 of 13ENSP00000565528.1

Frequencies

GnomAD3 genomes
AF:
0.00743
AC:
1131
AN:
152176
Hom.:
14
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0257
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00765
GnomAD2 exomes
AF:
0.00207
AC:
520
AN:
251458
AF XY:
0.00155
show subpopulations
Gnomad AFR exome
AF:
0.0268
Gnomad AMR exome
AF:
0.00162
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000185
Gnomad OTH exome
AF:
0.000651
GnomAD4 exome
AF:
0.000850
AC:
1242
AN:
1461874
Hom.:
6
Cov.:
31
AF XY:
0.000747
AC XY:
543
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.0274
AC:
918
AN:
33480
American (AMR)
AF:
0.00195
AC:
87
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00122
AC:
7
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000854
AC:
95
AN:
1112008
Other (OTH)
AF:
0.00215
AC:
130
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
82
163
245
326
408
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00745
AC:
1135
AN:
152294
Hom.:
14
Cov.:
32
AF XY:
0.00718
AC XY:
535
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0258
AC:
1071
AN:
41548
American (AMR)
AF:
0.00236
AC:
36
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68030
Other (OTH)
AF:
0.00757
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
58
115
173
230
288
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000873
Hom.:
0
Bravo
AF:
0.00866
ESP6500AA
AF:
0.0254
AC:
112
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00249
AC:
302
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Neuronal ceroid lipofuscinosis 2 (3)
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
16
DANN
Benign
0.73
DEOGEN2
Benign
0.26
T
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.84
T
MetaRNN
Benign
0.0070
T
MetaSVM
Benign
-0.43
T
MutationAssessor
Benign
0.84
L
PhyloP100
1.3
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.62
N
REVEL
Benign
0.20
Sift
Benign
0.73
T
Sift4G
Benign
0.79
T
Polyphen
0.012
B
Vest4
0.34
MVP
0.85
MPC
0.21
ClinPred
0.0018
T
GERP RS
0.79
Varity_R
0.12
gMVP
0.69
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112812685; hg19: chr11-6637264; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.